were set to NA. Three housekeeping genes (EEF1A1, FAM105B, and MYL12B/MRLC2) were selected out of eight possibilities based on M values as previously described (1) and their geometric mean was subtracted from the other samples on a per-plate basis to give a deltaCt value that corrects for differing sample amounts. The average of two reference samples was subtracted from each deltaCt value on a per-plate basis to correct for plate batch effects to give a FC compared to reference samples. The reference samples used were an inhouse pool and a commercial pool: FirstChoice® Human Total RNA Survey Panel (AM6000 from Life Technologies). Finally, the mean of the delta deltaCt values for control samples was subtracted from each sample and the fold change relative to controls was calculated as follows: FC = 2 ^ (-delta deltaCt). are provided with corresponding probes and their annotations.
Interferon Modules and related genes

Public domain datasets
Publicly available blood gene-expression profiles from pediatric and adult independent SLE cohorts (Arrasapan 2011 -access to data graciously provided through ArrayTrack™ tool, FDA National Center for Toxicological Research, Jefferson, AR, USA; Berry and Pascual 2010, GSE22098) were used to validate IFN modular signatures observed in our cohort.
Blood gene-expression profiles from patients infected with hepatitis C virus (HCV) treated with , where samples at day 6 of treatment are compared to baseline or from patients with multiple sclerosis treated with , where samples at months 3, 12 and 24 of treatment are compared to baseline (Malhotra 2011, GSE26104; Taylor 2008, GSE11342) were used to evaluate the influence of various types of IFN on the modular IFN signature.
Interferome database
The filter in Interferome was set as follows: species=human, exclusion= fetal brain, embryo, umbilical vein. Genes were defined as "IFN-related" if they were responsive to at least one type of IFN (expression FC>2) after in vitro stimulation with IFN (compared to baseline "quiescent" group included SLE patients at their first available visit with low disease activity, defined by no flare-up or treatment modifications for at least 60 days prior to the visit, and a SLEDAI of ≤4. The "longitudinal" group included SLE patients who had at least three consecutive visits during the study. 53 (85) 30 (88) 24 (83) 17 (85) Ethnicity, n (%) White Black Asian .
(89) 4 (6) 3 (5)
. 29 (85) 3 (9) 2 (6) . 26 (90) 2 (7) 1 (3) (16) 18 (29) 1 (1.6) 52 (84) 16 genes belonging to the 3 IFN modules and which primers were available in the lab at the time of the study were used for qPCR validation (see Figure S5 ). From this list of 16, a panel of 9 genes was generated by random forest to end with a list of 3 genes belonging to each of the 3 IFN modules: IFI44, XAF1 and SPATS2L for M1.2; MOV10, GALM and TIMM10 for M3.4; and LBA1, TRIM38 and TRIM56 for M5.12. 
The number and names of genes of each score is provided, as well as the IFN modules to which these genes belong. Most genes composing these scores belong to M1.2 (the most sensitive and the less variable IFN module), some belong to M3.4, but very few belong to M5.12 (the most variable module, upregulated only after the 2 others). 
TNFSF13B (BAFF)
Functional annotation of genes in networks was performed using the web-based tool DAVID (http://david.abcc.ncifcrf.gov). Blood gene expression data identified differentially expressed transcripts (n=209) in quiescent SLE patients compared to healthy controls (Benjamini-Hochberg FDR <0.05, FC ≥ 2).
A: A list of unique gene symbol derived from upregulated transcripts (n=171) was entered in the Interferome database and identified 75 unique "IFN-related" genes. The corresponding transcripts (n=85) were used to calculate an "IFN molecular distance to health" for each sample. In quiescent SLE patients, this "IFN molecular distance to health" was strongly correlated to the modular IFN score (Pearson correlation = 0.946, p < 0.0001).
B:
The 64 quiescent samples were ordered according to their modular IFN score and hierarchical clustering of differentially expressed probes (SLE versus healthy controls) was performed with Pearson correlation as the distance metric. Pathway analysis revealed several clusters of up-regulated genes that were correlated with the modular classification of samples.
Functional annotation of genes in networks (see Table S9 ) was performed using the webbased tool DAVID (http://david.abcc.ncifcrf.gov) and visualized using the online STRING interface (http://string-db.org). 
